key: cord-0983872-xmewcbmd
authors: Mohamed Hussein, Aliae A.R.; Galal, Islam; Makhlouf, Nahed A.; Makhlouf, Hoda A; Abd- Elaal, Howaida K.; Kholief, Karima M.S.; Saad, Mahmoud M.; Attay, Dina A.E.; Abdel Tawab, Doaa A.
title: Acceptance of COVID-19 vaccines among medical teams in Egypt
date: 2021-09-14
journal: Arab J Gastroenterol
DOI: 10.1016/j.ajg.2021.09.001
sha: c3aba946d38850ae2ea54852a22462479105f8e9
doc_id: 983872
cord_uid: xmewcbmd

nan

The COVID-19 outbreak poses a grave threat to human health [1] ; thus, investigators are competing to develop and study COVID-19 vaccines [2] . Once vaccines become available, the success of immunization will still depend on the community's acceptance of the vaccines. Although most people would agree to receive a novel vaccine against COVID-19 [3] [4] [5] , approximately a quarter of them would refuse [4, 6, 7] .

In 2020, international organizations and national regulatory authorities in collaboration with multinational pharmaceutical industries directed their efforts for developing COVID-19 vaccines as the pandemic continues. By the end of 2020, five vaccines have been authorized to be used on an emergency use authorization (EUA) basis in the USA [8] . In Egypt and up till now the preparation the Ministry of Health offers two vaccines for its population (an inactivated vaccine and a vector based vaccine Healthcare workers (HCWs) can be both source of infection and illness victims [9] . Kassem et al. [10] reported that the point prevalence of COVID-19 in gastroenterology HCWs is 13.5% in a tertiary care facility in Egypt. Thus, HCWs should be protected from COVID-19 contagion, not only to protect themselves but also for protection of their families and patients as well. The World Health Organization (WHO) had planned to prioritize healthcare professionals for COVID-19 immunization [1] . However, the issue of obligatory vaccination against COVID-19 for healthcare professionals remains debatable. Canal and Red Sea cities, respectively. Among these respondents, 34.9% were male, and 65.1% were female. Concerning age groups 55%, 37.5%, 7.1%, and 0.4% were 18-45, 26-45, 46-65, and >65 years old, respectively.

In terms of profession, among the 488 participants responded that they were medical students (39.8%), physicians (30.9%), nurses (17.2%), medical school staff members (4.5%), laboratory workers (4.5%), and technicians (3.1%).

With regard to COVID-19 vaccination acceptance (488 responses), only 66 (13.5%) totally agreed, 158 (32.4%) somewhat agreed, and 64 (13.2%) were undecided. Therefore, 200 (40.9%) disagreed to take the vaccine.

These results indicate that the medical teams are generally willing to accept the vaccine; however, the "somewhat agree" statement may indicate hesitancy and background-specific concern in accepting the new vaccine. This hesitancy was confirmed when the participants were asked about the causes of vaccination disapproval. The causes of disapproval were as follows: unsafe nature of the vaccine, fear of genetic mutation, uncertainty about the recent techniques, and belief that the vaccine is not effective (57%, 20.2%, 17.7%, and 16.6%, respectively). Furthermore, 57% of the participants said that the vaccine is "not safe clinically," indicating the lack of reassurance regarding vaccine safety and future unknown adverse events.

According to our survey, although a higher percentage of the participants are willing to accept the vaccine, the acceptance is considered low. The vaccine hesitancy among Egyptian medical teams can be the major barrier to the widespread acceptance of COVID-19 vaccination in Egypt. A global survey with 13,426 participants from 19 countries assessed the potential of COVID-19 vaccine acceptance and showed that differences in the acceptance were 80% in Asian nations and <55% in Russia [13] . Therefore, the acceptance of the vaccine is expected to be low in Egypt, considering that vaccine hesitancy exists globally.

Taken together, fear from the rapid release of the vaccine to the public and the lack of research on Arab populations may have led to increased uncertainty about the importance of receiving the newly developed vaccines. Vaccine hesitancy is common in HCWs and medical students in Egypt, indicating an alarming barrier to vaccine acceptance in the rest of the population. Therefore, conducting campaigns is urgently needed to increase awareness of the importance of COVID-19 vaccines.

Compliance with ethics requirements: Approved by the ethical committee was done.

Declaration of competing Interest: The authors declare that they have no conflicts of interest.

World Health Organization. WHO. WHO Director-General's opening remarks at the media briefing on COVID 19

Genebra: World Health Organization

Vaccines the race for coronavirus vaccines

Impact of COVID-19 and health system performance on vaccination hesitancy: Evidence from a two-leg representative survey in the UK. Available at SSRN 3627335

Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic

Willingness to vaccinate against COVID-19 in Australia. The Lancet. Infectious Diseases

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet. Infectious diseases

The French public's attitudes to a future COVID-19 vaccine: the politicization of a public health issue

Emergency Use Authorization for Vaccines Explained. U.S. Food and Drug Administration

First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit

World Health Organization. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination

World Health Organization; 2020. Ten health issues WHO will tackle this year n

A global survey of potential acceptance of a COVID-19 vaccine